Home » Topics » Regulatory » Patents

Patents
RSS

Fibrinogen antagonists from Merck & Co.

July 19, 1996

BASF reveals thrombin inhibitor as thrombosis/arterial reocclusion therapy

July 19, 1996

FO-2047: Kitasato Institute's lipid peroxidation inhibitor

July 19, 1996

LDL oxidation inhibitors as arteriosclerosis/myocardial ischemia treatment from Chugai

July 19, 1996

Benzofuran smooth muscle proliferation inhibitors from Lilly

July 19, 1996

Potential hypertension treatment from Pola

July 19, 1996

NEP inhibitors described by Tanabe Seiyaku

July 19, 1996

Angiotensin II antagonists described by Kotobuki Seiyaku

July 19, 1996

5-Lipoxygenase inhibitors reported by Pfizer

July 19, 1996

Muscarinic cholinergic ligands described by Novo Nordisk

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Medline raises $6.3B in fourth med-tech IPO of December
BioWorld MedTech
Medline Inc. returned to the public markets with a blockbuster IPO of $6.26 billion, reportedly this year’s largest IPO globally. The upsized offering of more...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
Vitesse finesse pays off: DBV wins in peanut allergy phase III
BioWorld
DBV Technologies SA’s pivotal phase III trial with the Viaskin Peanut allergy patch came through for the company, and officials plan a BLA filing with the U.S....
Acryl raises $28M IPO, aiming to bridge medical divide with AI
BioWorld MedTech
Acryl Inc. debuted on South Korea’s Kosdaq Dec. 16, raising ₩42.12 billion ($28.5 million) in an IPO. Shares (KOSDAQ:0007C0) closed at ₩67,000 on the first day,...